EN DE

Cosmecca Korea Co (241710) Fair Value & Analysis

Consumer Defensive · KR · Market cap 830B KRW

CK Cosmecca Korea Co 241710 · KQ
Price95,000 KRW
Fair Value89,348 KRW
Upside-6.0%
Quality53/100
Watch Cosmecca Korea Co for free, get notified when fair value or trend changes. Watch for free
Expensive Growth
Thin margins · 7.8% net margin
Low debt · negative free cash flow
0.44% dividend yield
Mixed vs. peers (5/9)
Moderate moat 59/100
Evidence: Medium Range 67,011 KRW – 111,685 KRW Share as image

Fair value as of: Jul 20, 2026

From 15 valuation models · updated 21 days ago

Share price +14.5% over the past month.

A solid business, currently priced close to our fair value.

What matters now

  • The price sits close to our fair value, market and models broadly agree here, little valuation tension.
  • Our model range runs from 67,011 KRW (bear) to 111,685 KRW (bull), base 89,348 KRW. The closer the price sits to the lower half, the larger the margin of safety.
  • Quality 53/100 (solid quality) with medium evidence: read the verdict with care.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

103,000 KRW 6,478 KRW Fair Value 89,348 KRW Mar 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 20, 2026.

How to read this chart

60‑month range 6,478 KRW – 103,000 KRW · fair‑value band 67,011 KRW – 111,685 KRW · the 95,000 KRW price screens above the 89,348 KRW fair value. Dashed = 300-day average. As of Jul 20, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Cosmecca Korea Co (241710) currently trades at 95,000 KRW, while our model-based Fair Value estimate is 89,348 KRW, implying the stock looks roughly 6.0% fairly valued today. The Quality Score stands at 53/100 (solid quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).

Over the trailing twelve months, Cosmecca Korea Co generated revenue of 708B KRW at a net margin of 7.8%. Revenue grew 56.4% year over year. It earns a return on equity of 22.7%. Net debt stands at 96.6B KRW. Fundamentals as of Jul 20, 2026

Our scenario range runs from 67,011 KRW (bear case) to 111,685 KRW (bull case); at 95,000 KRW, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 11% below its 52-week high and 78% above its 52-week low, currently above its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -26% fair-value upside, at -6%, 241710 screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Residual Income 29,341 KRW 38,861 KRW 152,277 KRW 76
ROIC Compounder 86,035 KRW 117,089 KRW 158,571 KRW 72
Growth-Adj P/E 68,837 KRW 98,338 KRW 127,840 KRW 68
All 15 models by family
DCF Models
Owner Earnings 4,377 KRW 5,119 KRW 6,592 KRW 31
Earnings-Based
Graham-Dodd 28,932 KRW 164,491 KRW 228,634 KRW 54
Lynch FV 46,223 KRW 66,033 KRW 85,842 KRW 50
PEG = 1.0 46,223 KRW 66,033 KRW 85,842 KRW 46
EPV 74,075 KRW 86,498 KRW 97,540 KRW 59
Multiples
P/E Multiple 67,011 KRW 89,348 KRW 111,685 KRW 63
P/S Multiple 54,247 KRW 72,329 KRW 90,412 KRW 58
P/B Multiple 54,247 KRW 72,329 KRW 90,412 KRW 55
EV/EBIT 103,407 KRW 136,649 KRW 169,892 KRW 53
EV/EBITDA 95,015 KRW 125,461 KRW 155,906 KRW 54
EV/Revenue 66,691 KRW 93,697 KRW 120,702 KRW 43
Asset-Based
NCAV (Graham) 11,832 KRW 15,854 KRW 23,663 KRW 50
Economic Profit
Residual Income 29,341 KRW 38,861 KRW 152,277 KRW 76
ROIC Compounder 86,035 KRW 117,089 KRW 158,571 KRW 72
Growth Earnings
Growth-Adj P/E 68,837 KRW 98,338 KRW 127,840 KRW 68

Widest divergence: Growth Earnings (98,338 KRW) versus DCF Models (5,119 KRW). Highest evidence: Residual Income (76).

Notify me when 241710 reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) 708B KRW
Revenue growth (YoY) +56.4%
Net margin 7.8%
Return on equity 22.7%
Free cash flow −6.4B KRW FY2025
Operating margin 11.8%
More key figures
Dividend yield 0.5%
EPS growth (YoY) +127%
Net debt 96.6B KRW FY2025

Figures from reported company fundamentals · as of Jul 20, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 53/100

Of which business quality 53 · Market factors (momentum, volatility) 57

Profitability 55
Margins and returns on capital today
Quality Growth 60
Are margins and returns improving?
Cashflow 25
Earnings quality: real cash, not paper profit
Fin. Strength 72
Balance sheet, leverage, solvency risk
Investment 24
Disciplined investing over empire-building
Low Volatility 31
Calm price path (market factor)
Momentum 63
Price trend over the last 3–12 months (market factor)
52W Momentum 78
Distance to the 52-week high (market factor)
Net Issuance 82
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Cosmecca Korea Co., Ltd. engages in the research and development, manufacture, and sale of skincare products in South Korea and internationally.

Full company description

Cosmecca Korea Co., Ltd. engages in the research and development, manufacture, and sale of skincare products in South Korea and internationally. It offers skincare products, including lotion/toner, cream, essence, cleansers, Korean herbal products, mask sheet, scalp care, home scents, body and bath, exfoliators, and treatment products, as well as products for men, babies, and children; functional skincare products, which includes brightening, wrinkle and fine line, UV blocks/sunscreen, tanning, multi-functional, hair and body, and acne care products; and makeup products, such as BB and CC cream, skin cover balms, makeup base, foundation, concealer, lipstick, mascara, eyeliner, eyeshadow, blush/highlighter, and powders. The company was incorporated in 1999 and is headquartered in Eumseong-eup, South Korea.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Cosmecca Korea Co reported revenue of 641B KRW in FY2025 versus 396B KRW in FY2021, a compound +12.8%/yr. Reported net income was 45.4B KRW in FY2025, compounding +50.3%/yr from FY2021.

Growth Quality 62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Latest Revenue (FY 2025)
641B KRW
Latest YoY
+22.2%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+17.1%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+13.6%
Avg. growth/yr (9Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+16.3%
Revenue +12.8%/yr
FY21 396B KRW
FY22 399B KRW
FY23 471B KRW
FY24 524B KRW
FY25 641B KRW
Net income +50.3%/yr
FY21 8.9B KRW
FY22 2.7B KRW
FY23 22.3B KRW
FY24 42.8B KRW
FY25 45.4B KRW

Watch 241710: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Cosmecca Korea Co Fair Value". https://www.fairvalue-calculator.com/stock/241710

Peer Group

Household & Personal Products · 244 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 53 · Below median
Fair Value upside −6% · Below median
Return on equity (TTM) 23% · Top 25%
Return on assets 10% · Top 25%
Net margin (TTM) 8% · Above median
Operating margin (TTM) 12% · Above median
Revenue growth 56% · Top 25%
Dividend yield (TTM) 0.4% · Bottom 25%
Debt / equity 0.12× · Higher than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 25 · sector 28
FUTURE 100 · sector 4
PAST 91 · sector 26
HEALTH 94 · sector 98
DIVIDEND 9 · sector 50

Insider activity: 45/100

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Jul 20, 2026).

Stock Price Fair Value vs Fair Value
The Procter & Gamble Company PG $146.80 $108.16 -26%
Unilever PLC ULN 1,080 MXN 1,273 MXN +18%
Hindustan Unilever Limited HINDUNILVR ₹2,144 ₹1,000 -53%
Essity AB ESSITYA kr 279.00 kr 250.02 -10%
Godrej Consumer Products Limited GODREJCP ₹1,088 ₹367.64 -66%
Marico Limited MARICO ₹846.75 ₹233.05 -72%
APR Co 278470 375,000 KRW 151,222 KRW -60%
Dabur India Limited DABUR ₹429.45 ₹181.60 -58%
Kimberly-Clark de México, S. A. B. de C. V., KIMBERA 38.07 MXN 50.09 MXN +32%
PT Unilever Indonesia Tbk UNVR 1,730 IDR 1,934 IDR +12%

Compare Cosmecca Korea Co with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Cosmecca Korea Co (241710) overvalued or undervalued?
As of Jul 20, 2026, our model estimates a fair value of 89,348 KRW versus a price of 95,000 KRW, about −6% (fairly valued).
What is the fair value of 241710?
Our model-based fair value for Cosmecca Korea Co is 89,348 KRW (as of Jul 20, 2026), built from audited fundamentals. The current price is 95,000 KRW.
What is the quality score of 241710?
Cosmecca Korea Co has a Quality Score of 53/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Cosmecca Korea Co (241710)?
Cosmecca Korea Co reported trailing-twelve-month revenue of about 708B KRW (latest available figure, as of Jul 20, 2026).
What is the net profit margin of 241710?
The net profit margin of Cosmecca Korea Co is about 7.8%, meaning it keeps roughly 7.8% of revenue as net income. Based on the latest reported figures.
Does Cosmecca Korea Co pay a dividend?
Cosmecca Korea Co currently shows a dividend yield of about 0.53% relative to its recent price (as of Jul 20, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Cosmecca Korea Co and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.